Sarepta Therapeutics plans to raise $375m through the private placement of convertible senior unsecured notes.
Due 15 November 2024, the notes were subscribed to by institutional buyers.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The US-based biopharmaceutical company plans to use the funds to strengthen its balance sheet and for general corporate purposes.
US-based pharmaceutical company Cumberland Pharmaceuticals plans to make a public offering of shares to raise $25m.
The company intends to use the funds towards working capital and general corporate purposes.
CTI BioPharma plans to raise $200m through a public offering of securities issued from time to time.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe securities will include common stock, preferred stock, warrants, rights and units.
The US-based biopharmaceutical company plans to use the funds towards general corporate purposes.
Natco Pharma has announced a public offering of shares to raise Rs15bn ($231.92m).
The Indian pharmaceutical company plans to use the funds to strengthen its domestic formulation business.
